Award
National Institute of Allergy and Infectious Diseases 5R01AI174461-04
Development of Targeted Antipseudomonal Bactericidal Prodrugs
Recipient
Cornell University
Award Amount
$446,412.00
Ceiling
$446,412.00
Awarded
January 06, 2026
Identifier
5R01AI174461-04
Award for developing targeted bactericidal prodrugs to combat Pseudomonas aeruginosa infections, focusing on overcoming antibiotic resistance and toxicity.
Description
This project aims to develop targeted antibody bactericide conjugates to treat Pseudomonas aeruginosa bloodstream infections, addressing antibiotic resistance and toxicity issues.